KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Discontinued Operations: 2010-2012

Historic Cash from Discontinued Operations for Opko Health (OPK) over the last 2 years, with Dec 2012 value amounting to -$7,000.

  • Opko Health's Cash from Discontinued Operations rose 97.51% to -$7,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $7,000, marking a year-over-year increase of 100.15%. This contributed to the annual value of $7,000 for FY2012, which is 100.15% up from last year.
  • According to the latest figures from Q4 2012, Opko Health's Cash from Discontinued Operations is -$7,000, which was down 107.29% from $96,000 recorded in Q3 2012.
  • Opko Health's Cash from Discontinued Operations' 5-year high stood at $96,000 during Q3 2012, with a 5-year trough of -$1.6 million in Q3 2011.
  • For the 3-year period, Opko Health's Cash from Discontinued Operations averaged around -$575,556, with its median value being -$281,000 (2011).
  • Data for Opko Health's Cash from Discontinued Operations shows a peak YoY spiked of 106.04% (in 2012) over the last 5 years.
  • Opko Health's Cash from Discontinued Operations (Quarterly) stood at -$626,000 in 2010, then surged by 55.11% to -$281,000 in 2011, then skyrocketed by 97.51% to -$7,000 in 2012.
  • Its Cash from Discontinued Operations stands at -$7,000 for Q4 2012, versus $96,000 for Q3 2012 and -$157,000 for Q2 2012.